Literature DB >> 21129333

The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed.

Peter A Baghurst1, David Rodbard, Fergus J Cameron.   

Abstract

AIMS: While there has been much debate about the clinical importance of glycemic variation (GV), little attention has been directed to the properties of data sets from which it is measured. The purpose of this study is to assess the minimum frequency of glucose measurements from which GV can be consistently and meaningfully measured.
METHODS: Forty-eight 72 h continuous glucose monitoring traces from children with type 1 diabetes were assessed. Measures of GV included standard deviation (SD), mean amplitude of glycemic excursion (MAGE), and continuous overlapping net glycemic action (CONGA1-4). Measures of GV calculated using 5 min sampling were designated as the 100% or "best estimate" value. Calculations were then repeated for each patient using glucose values spaced at increasing intervals. For each of the specified sampling frequencies, the ratio (%) of the between-subject SD based on the reduced subset of data to the estimate of the SD based on the full 5 min sampling data set was calculated.
RESULTS: As the interval between observations increased, so did the variability of the estimators of GV. Standard deviation exhibited the least systematic change at all measurement intervals, and MAGE exhibited the greatest systematic change.
CONCLUSIONS: In patients with type 1 diabetes, GV as measured by SD or CONGA4, becomes unreliable if observations are more than 2-4 h apart, and estimates of MAGE become unreliable if glucose measurements are more than 1 h apart. MAGE is more unstable and prone to random measurement error than either SD or CONGA. The frequency of glycemic measurements is thus pivotal when selecting a parameter for measurement of GV.
© 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129333      PMCID: PMC3005048          DOI: 10.1177/193229681000400612

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  12 in total

1.  Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm.

Authors:  Peter A Baghurst
Journal:  Diabetes Technol Ther       Date:  2011-02-03       Impact factor: 6.118

2.  New approaches to display of self-monitoring of blood glucose data.

Authors:  David Rodbard
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

Review 3.  Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.

Authors:  L Nalysnyk; M Hernandez-Medina; G Krishnarajah
Journal:  Diabetes Obes Metab       Date:  2010-04       Impact factor: 6.577

4.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

Review 5.  For debate. Glucose variability and diabetes complication risk: we need to know the answer.

Authors:  E S Kilpatrick; A S Rigby; S L Atkin
Journal:  Diabet Med       Date:  2010-08       Impact factor: 4.359

6.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

7.  A novel approach to continuous glucose analysis utilizing glycemic variation.

Authors:  C M McDonnell; S M Donath; S I Vidmar; G A Werther; F J Cameron
Journal:  Diabetes Technol Ther       Date:  2005-04       Impact factor: 6.118

8.  Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?

Authors:  J Bragd; U Adamson; L B Bäcklund; P E Lins; E Moberg; P Oskarsson
Journal:  Diabetes Metab       Date:  2008-09-27       Impact factor: 6.041

9.  Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.

Authors:  S E Siegelaar; E S Kilpatrick; A S Rigby; S L Atkin; J B L Hoekstra; J H Devries
Journal:  Diabetologia       Date:  2009-08-12       Impact factor: 10.122

10.  Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more
  16 in total

1.  Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors:  Renata A Rawlings; Hang Shi; Lo-Hua Yuan; William Brehm; Rodica Pop-Busui; Patrick W Nelson
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

Review 2.  The challenges of measuring glycemic variability.

Authors:  David Rodbard
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  Minding the gaps in continuous glucose monitoring: a method to repair gaps to achieve more accurate glucometrics.

Authors:  Stephanie J Fonda; Drew G Lewis; Robert A Vigersky
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 4.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

5.  A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.

Authors:  David C Klonoff; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2017-09-08

6.  Glucose Management Technologies for the Critically Ill.

Authors:  Pedro D Salinas; Carlos E Mendez
Journal:  J Diabetes Sci Technol       Date:  2019-01-13

Review 7.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

8.  The Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed.

Authors:  Orla M Neylon; Peter A Baghurst; Fergus J Cameron
Journal:  J Diabetes Sci Technol       Date:  2014-02-09

9.  Effects of fluctuating glucose levels on neuronal cells in vitro.

Authors:  Vincenzo C Russo; Sandra Higgins; George A Werther; Fergus J Cameron
Journal:  Neurochem Res       Date:  2012-05-08       Impact factor: 3.996

10.  Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application.

Authors:  Stephanie J Fonda; Sara J Salkind; M Susan Walker; Mary Chellappa; Nicole Ehrhardt; Robert A Vigersky
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.